Hemoglobin and Iron Metabolism Practice Questions

Q: What is the transport form of iron in the body?

Transferrin. **Explanation:** Iron metabolism is a high-yield topic in Biochemistry, centered on the movement and storage of iron in different states. **1. Why Transferrin is Correct:** Iron is transported in the blood in the **ferric state (Fe³⁺)**. Because free iron is toxic and can generate free radicals via the Fenton reaction, it must be bound to a carrier protein. **Transferrin** is a glycoprotein synthesized in the liver that specifically binds two molecules of Fe³⁺ for safe transport through the plasma to various tissues (like bone marrow for erythropoiesis). **2. Why the Other Options are Incorrect:** * **Ferritin:** This is the primary **intracellular storage form** of iron. It is found mainly in the liver, spleen, and bone marrow. Serum ferritin levels are the most sensitive indicator of body iron stores. * **Apoferritin:** This is the protein shell of ferritin **without** the iron core. Once iron enters the cell and binds to apoferritin, it becomes ferritin. * **Lactoferrin:** This is an iron-binding protein found in exocrine secretions (milk, saliva, tears) and neutrophil granules. It has antimicrobial properties by sequestering iron away from bacteria but is not the systemic transport form. **Clinical Pearls for NEET-PG:** * **State of Iron:** Iron is absorbed in the **Ferrous (Fe²⁺)** state ("Fe-2 goes in-too") but transported and stored in the **Ferric (Fe³⁺)** state. * **Hepcidin:** The "Master Regulator" of iron metabolism. It inhibits **Ferroportin**, preventing iron release from enterocytes and macrophages. * **TIBC (Total Iron Binding Capacity):** This is an indirect measure of transferrin levels. In Iron Deficiency Anemia (IDA), TIBC increases while Ferritin decreases.

Q: Bilirubin is synthesized from which of the following?

Hemoglobin. **Explanation:** Bilirubin is the end product of **heme catabolism**. Approximately 80–85% of bilirubin is derived from the breakdown of **hemoglobin** from senescent (old) red blood cells in the Reticuloendothelial System (spleen, liver, and bone marrow). **Why Hemoglobin is Correct:** When RBCs reach the end of their 120-day lifespan, they are sequestered in the spleen. Hemoglobin is broken down into globin and heme. The enzyme **Heme Oxygenase** acts on heme to produce **Biliverdin**, which is then reduced by **Biliverdin Reductase** to form **unconjugated bilirubin**. This bilirubin is then transported to the liver bound to albumin. **Why Other Options are Incorrect:** * **Amino acids:** While amino acids are the building blocks of the *globin* chains, they are recycled into the body's protein pool and do not directly form bilirubin. * **Myoglobin:** Although myoglobin contains heme and its breakdown contributes to bilirubin production, it accounts for only a small fraction (along with cytochromes) compared to the massive turnover of hemoglobin. * **WBCs:** White blood cells do not contain hemoglobin or heme-based oxygen carriers; therefore, their degradation does not produce bilirubin. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** Heme Oxygenase is the rate-limiting enzyme in bilirubin synthesis. * **Color changes:** Heme (purple) → Biliverdin (green) → Bilirubin (yellow). This sequence is visible in the changing colors of a healing bruise. * **Excretion:** Bilirubin must be conjugated with **Glucuronic acid** in the liver (by UDP-glucuronosyltransferase) to become water-soluble for excretion in bile. * **Van den Bergh Reaction:** Used to differentiate between conjugated (Direct) and unconjugated (Indirect) bilirubin.

Q: Porphyrins are synthesized mainly in which organs?

Liver and Bone marrow. ### Explanation **Correct Answer: D. Liver and Bone Marrow** Porphyrin synthesis is the metabolic pathway leading to the production of **Heme**. The synthesis occurs in almost all mammalian cells, but the primary sites are the **liver** and the **erythroid precursor cells of the bone marrow**. 1. **Bone Marrow (~85%):** Here, heme is synthesized for the production of **hemoglobin**, which is essential for oxygen transport in developing red blood cells. 2. **Liver (~15%):** In hepatocytes, heme is primarily used for the synthesis of **Cytochrome P450 enzymes**, which are crucial for drug metabolism and detoxification. **Why other options are incorrect:** * **Spleen (Options A, B, and C):** The spleen is primarily the site of **heme degradation** (catabolism), not synthesis. In the spleen, senescent red blood cells are broken down, and heme is converted into bilirubin via the action of heme oxygenase. It does not contribute significantly to the de novo synthesis of porphyrins. **High-Yield Clinical Pearls for NEET-PG:** * **Subcellular Localization:** Porphyrin synthesis is unique because it occurs compartmentalized between the **mitochondria** and the **cytosol**. * **Rate-Limiting Step:** The first step, catalyzed by **ALA Synthase (ALAS)**, is the rate-limiting step. * **ALAS-1** is found in the liver (inhibited by heme/hemin). * **ALAS-2** is erythroid-specific (regulated by iron availability). * **Lead Poisoning:** Lead inhibits two key enzymes in this pathway: **ALA Dehydratase** and **Ferrochelatase**, leading to sideroblastic anemia and elevated ALA levels. * **Porphyrias:** Genetic defects in the enzymes of this pathway lead to Porphyrias, characterized by either neuropsychiatric symptoms or cutaneous photosensitivity.

Q: In porphyria cutanea tarda, what type of porphyrin is excreted in the urine?

Type I and III uroporphyrins. **Explanation:** **Porphyria Cutanea Tarda (PCT)** is the most common type of porphyria. It results from a deficiency of the enzyme **Uroporphyrinogen Decarboxylase (UROD)**. 1. **Why the correct answer is right:** Under normal physiological conditions, UROD converts Uroporphyrinogen III into Coproporphyrinogen III. When UROD is deficient, its substrate—**Uroporphyrinogen III**—accumulates in the liver. This excess uroporphyrinogen is non-enzymatically oxidized into **Uroporphyrin III**, which is then excreted in the urine. Additionally, due to the metabolic shunt caused by the block, there is an increased production and excretion of **Uroporphyrin I**. Therefore, the hallmark urinary finding in PCT is a significant elevation of both **Type I and III uroporphyrins**. 2. **Why incorrect options are wrong:** * **Option A:** Coproporphyrin-I is typically elevated in Dubin-Johnson syndrome or certain secondary porphyrinurias, but it is not the primary diagnostic marker for PCT. * **Option B & C:** While Uroporphyrin-I is elevated, it does not occur in isolation. Uroporphyrin-II is not a naturally occurring isomer in human heme synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Characterized by **photosensitivity**, skin fragility, and blistering (vesicles/bullae) on sun-exposed areas (back of hands). * **Risk Factors:** Often triggered by alcohol consumption, iron overload (hemochromatosis), Hepatitis C, or estrogen use. * **Diagnosis:** Urine shows "tea-colored" or "port-wine" appearance and exhibits **pink-red fluorescence** under Wood’s lamp. * **Treatment:** Phlebotomy (to reduce iron) or low-dose chloroquine.

Q: Which of the following statements is false regarding the Bohr effect?

It is also exhibited by myoglobin.. The **Bohr effect** describes the decrease in hemoglobin's oxygen affinity in response to increased acidity (low pH) and high $CO_2$ concentration. This mechanism ensures that oxygen is released efficiently to metabolically active tissues. ### Why Option C is the Correct Answer (False Statement) The Bohr effect is an **allosteric property** that requires a quaternary structure (multiple subunits). **Myoglobin** is a monomeric protein (single polypeptide chain). Because it lacks multiple subunits and the ability to shift between T (tense) and R (relaxed) states, it does not show cooperativity or the Bohr effect. Its oxygen dissociation curve is hyperbolic, not sigmoidal. ### Analysis of Other Options * **A. Reciprocal coupling of protons and $O_2$:** This is true. As $H^+$ binds to hemoglobin, $O_2$ is released (in tissues). Conversely, when $O_2$ binds to hemoglobin, $H^+$ is released (in lungs). * **B. Cooperative interactions:** The Bohr effect depends on the transition between the T-state (low affinity) and R-state (high affinity). This transition is the hallmark of the hemoglobin tetramer’s cooperative nature. * **D. Rupture of salt bridges:** In the T-state (deoxygenated), specific amino acids (like His146) form salt bridges that are stabilized by protons. When $O_2$ binds, these salt bridges rupture, releasing the protons. ### High-Yield Clinical Pearls for NEET-PG * **Right Shift Factors:** Factors that shift the Oxygen Dissociation Curve (ODC) to the **Right** (releasing $O_2$) include: **C**ADET, face **Right** (**C**O2, **A**cidosis/H+, **D**PG/2,3-BPG, **E**xercise, **T**emperature). * **Haldane Effect:** While the Bohr effect describes how $H^+/CO_2$ affect $O_2$ binding, the Haldane effect describes how **$O_2$ levels** affect hemoglobin's affinity for $CO_2$. * **Key Residue:** The most important amino acid involved in the Bohr effect is **Histidine 146** of the $\beta$-chain.

Q: What is the primary protein responsible for iron homeostasis?

Transferrin. **Explanation:** **Correct Answer: C. Transferrin** Iron homeostasis is primarily regulated through the transport and distribution of iron in the plasma. **Transferrin** is the principal iron-transport protein. It binds ferric iron ($Fe^{3+}$) with high affinity, ensuring it remains soluble and non-toxic while being delivered to tissues (especially the bone marrow for erythropoiesis) via transferrin receptors. By controlling the flux of iron between storage sites and utilization sites, it serves as the central hub for systemic iron homeostasis. **Analysis of Incorrect Options:** * **A. Ceruloplasmin:** This is a copper-containing ferroxidase. Its role is to oxidize $Fe^{2+}$ to $Fe^{3+}$ so iron can bind to transferrin. While essential for iron mobilization, it is not the primary homeostasis protein. * **B. Metallothionein:** This protein is primarily involved in the homeostasis and detoxification of heavy metals like **zinc and copper**, not iron. * **C. Ferritin:** This is the primary **intracellular storage** form of iron. While it reflects total body iron stores, it is a "reservoir" rather than the active regulator of systemic iron distribution. **High-Yield Clinical Pearls for NEET-PG:** * **Hepcidin Connection:** Hepcidin is the "master regulator" of iron; it decreases iron levels by degrading ferroportin. If the question asks for the *hormonal* regulator, choose Hepcidin. * **TIBC:** Total Iron Binding Capacity is an indirect measure of Transferrin levels. In Iron Deficiency Anemia (IDA), TIBC increases as the body tries to maximize transport. * **Saturation:** Normal transferrin saturation is approximately **33%**. * **Apotransferrin:** Transferrin without iron; **Holotransferrin:** Transferrin bound to iron.

Q: Iron absorption is decreased by all except?

Ascorbic acid. **Explanation:** Iron absorption is a tightly regulated process occurring primarily in the duodenum and upper jejunum. The correct answer is **Ascorbic acid (Vitamin C)** because it is a potent **enhancer** of iron absorption, whereas the other options are inhibitors. **Why Ascorbic Acid is Correct:** Dietary iron exists in two forms: Heme and Non-heme. Non-heme iron is usually in the ferric state ($Fe^{3+}$), which is insoluble and cannot be absorbed. Ascorbic acid facilitates absorption via two mechanisms: 1. **Reduction:** It reduces $Fe^{3+}$ to the ferrous state ($Fe^{2+}$), which is the form required for transport across the apical membrane via the **Divalent Metal Transporter 1 (DMT-1)**. 2. **Chelation:** It forms a soluble iron-ascorbate complex that remains stable in the alkaline environment of the small intestine. **Why Other Options are Incorrect:** * **Calcium:** It is the only known substance to inhibit the absorption of both heme and non-heme iron by competing for transport pathways. * **Tetracycline:** This antibiotic forms insoluble chelates with iron in the gut, preventing the absorption of both the drug and the mineral. * **Phytates (and Oxalates):** Found in cereals and green leafy vegetables, these bind to iron to form insoluble precipitates, significantly reducing bioavailability. **High-Yield Clinical Pearls for NEET-PG:** * **Hepcidin:** The master regulator of iron homeostasis; it inhibits iron release by degrading **Ferroportin**. * **Achlorhydria:** Gastric acid (HCl) is essential for iron absorption; thus, long-term Proton Pump Inhibitor (PPI) use or gastrectomy leads to iron deficiency. * **Tannins:** Found in tea, these are also potent inhibitors of non-heme iron absorption. * **Storage:** Iron is stored as **Ferritin** (labile) and **Hemosiderin** (stable).

Q: A child ingests paint chips and subsequently develops acute abdominal pain, paresthesias in the hands and legs, and weakness. Which enzyme is inhibited in this child?

ALA dehydratase. **Explanation:** The clinical presentation of abdominal pain, peripheral neuropathy (paresthesias and weakness), and a history of ingesting paint chips (a common source of lead in older buildings) is classic for **Lead Poisoning (Plumbism)**. **Why ALA Dehydratase is correct:** Lead is a heavy metal that inhibits heme synthesis by displacing zinc from the active sites of two key enzymes: **$\delta$-Aminolevulinic Acid (ALA) Dehydratase** and **Ferrochelatase**. * Inhibition of **ALA Dehydratase** leads to an accumulation of ALA in the blood and urine, which is neurotoxic and contributes to the abdominal pain and neurological symptoms. * Inhibition of **Ferrochelatase** prevents the incorporation of iron into protoporphyrin IX, leading to elevated erythrocyte protoporphyrin levels. **Why other options are incorrect:** * **A. ALA Synthase:** This is the rate-limiting enzyme of heme synthesis. It is inhibited by heme (feedback inhibition) and stimulated by drugs processed by the Cytochrome P450 system, but it is not a direct target of lead. * **B. Heme Oxygenase:** This enzyme is involved in heme **degradation** (converting heme to biliverdin), not synthesis. * **C. Coproporphyrinogen Oxidase:** This enzyme is inhibited in **Hereditary Coproporphyria**, an autosomal dominant porphyria, but is not the primary target in lead poisoning. **NEET-PG High-Yield Pearls:** * **Basophilic Stippling:** A characteristic finding on peripheral smear in lead poisoning due to the inhibition of pyrimidine 5'-nucleotidase, leading to ribosomal RNA degradation products. * **Burton’s Lines:** Bluish-purple lines on the gingival margins. * **Radiology:** "Lead lines" (hyperdense metaphyseal bands) may be seen on X-rays of long bones in children. * **Treatment:** Chelation therapy with **Succimer** (oral, first-line in kids), **CaEDTA**, or **Dimercaprol (BAL)**.

Q: Why do patients with sickle cell trait typically not experience manifestations similar to sickle cell disease?

50% HbS is required for the occurrence of sickling.. ### Explanation **1. Why Option A is Correct:** The primary pathophysiology of Sickle Cell Disease (SCD) is the polymerization of deoxygenated Hemoglobin S (HbS). In **Sickle Cell Trait (HbAS)**, the concentration of HbS is typically around **35–45%**, while HbA makes up the remaining 55–60%. For significant sickling to occur under physiological conditions, a threshold of **at least 50% HbS** is generally required. Because the HbS concentration in trait patients remains below this critical threshold, the red blood cells do not sickle under normal oxygen tension, leaving the patient asymptomatic. **2. Analysis of Incorrect Options:** * **Option B:** While HbA is present, it doesn't "prevent" sickling by its mere presence; rather, it dilutes the HbS concentration below the required threshold for polymerization. * **Option C:** This is factually incorrect. In sickle cell trait, less than 1% of cells are sickled in vivo under normal conditions. * **Option D:** HbA is relatively "inert" regarding polymerization. It does not actively inhibit HbS polymerization as effectively as **HbF (Fetal Hemoglobin)** does. HbF is a potent inhibitor of polymerization, which is why newborns with SCD are asymptomatic until HbF levels drop. **3. Clinical Pearls for NEET-PG:** * **The "Protective" Effect:** HbA2 and HbF are potent inhibitors of HbS polymerization; HbA is a weak inhibitor. * **Conditions for Sickling in Trait:** Patients with Sickle Cell Trait may experience sickling only under **extreme conditions** (severe hypoxia, acidosis, or extreme dehydration), such as unpressurized aircraft or high-altitude climbing. * **Renal Manifestation:** The most common clinical manifestation in Sickle Cell Trait is **Isosthenuria** (inability to concentrate urine) and painless **hematuria** due to micro-sickling in the hypertonic, hypoxic renal medulla. * **Electrophoresis:** HbAS shows HbA > HbS; HbSS shows no HbA.

Q: When milk is taken before a meal, which of the following elements' absorption is decreased?

Iron. **Explanation:** The correct answer is **Iron (B)**. This is a classic high-yield concept in nutrition biochemistry involving nutrient-nutrient interaction. **Why Iron is the correct answer:** Milk is a rich source of **calcium** and **casein** (phosphoprotein). Calcium is a potent inhibitor of both heme and non-heme iron absorption. It interferes with the transport of iron across the intestinal mucosal cells, likely by competing for transport proteins or affecting the expression of ferroportin. Clinical guidelines generally advise against consuming milk or calcium supplements simultaneously with iron-rich meals or iron supplements to prevent iron deficiency anemia. **Why other options are incorrect:** * **Calcium (A):** Taking milk before a meal does not decrease calcium absorption; in fact, milk is the primary vehicle for calcium delivery. Lactose in milk actually *enhances* calcium absorption by creating an acidic environment in the gut. * **Phosphorous (C):** Milk is high in phosphorus. While high phosphorus can theoretically bind calcium, it does not significantly inhibit its own absorption or the absorption of other minerals in this context. * **Magnesium (D):** While calcium and magnesium can compete for the same transporters at very high pharmacological doses, the calcium in a standard serving of milk does not significantly impair dietary magnesium absorption. **High-Yield NEET-PG Pearls:** * **Enhancers of Iron Absorption:** Vitamin C (Ascorbic acid) reduces $Fe^{3+}$ to $Fe^{2+}$, which is more soluble and easily absorbed. Gastric HCl also aids absorption. * **Inhibitors of Iron Absorption:** Phytates (cereals), Oxalates (spinach), Tannins (tea/coffee), and Calcium (milk). * **Milk Anemia:** A common pediatric condition where excessive cow's milk intake leads to iron deficiency due to low iron content in milk and the inhibition of other dietary iron sources.

Question 1

What is the transport form of iron in the body?

Accepted Answer

Transferrin

Answer

Ferritin

Answer

Apoferritin

Answer

Lactoferrin

Question 2

Bilirubin is synthesized from which of the following?

Accepted Answer

Hemoglobin

Answer

Amino acid

Answer

Myoglobin

Answer

WBCs

Question 3

Porphyrins are synthesized mainly in which organs?

Accepted Answer

Liver and Bone marrow

Answer

Spleen

Answer

Liver and spleen

Answer

Bone marrow and spleen

Question 4

In porphyria cutanea tarda, what type of porphyrin is excreted in the urine?

Accepted Answer

Type I and III uroporphyrins

Answer

Coproporphyrin - I

Answer

Uroporphyrin - I

Answer

Uroporphyrin - II

Question 5

Which of the following statements is false regarding the Bohr effect?

Accepted Answer

It is also exhibited by myoglobin.

Answer

It is the reciprocal coupling of protons and O2.

Answer

It depends on the cooperative interactions between the hemes of the hemoglobin tetramer.

Answer

Protons responsible for the effect arise from the rupture of salt bridges.

Question 6

What is the primary protein responsible for iron homeostasis?

Accepted Answer

Transferrin

Answer

Ceruloplasmin

Answer

Metallothionein

Answer

Ferritin

Question 7

Iron absorption is decreased by all except?

Accepted Answer

Ascorbic acid

Answer

Calcium

Answer

Tetracycline

Answer

Phytate

Question 8

A child ingests paint chips and subsequently develops acute abdominal pain, paresthesias in the hands and legs, and weakness. Which enzyme is inhibited in this child?

Accepted Answer

ALA dehydratase

Answer

ALA synthase

Answer

Heme oxygenase

Answer

Coproporphyrinogen oxidase

Question 9

Why do patients with sickle cell trait typically not experience manifestations similar to sickle cell disease?

Accepted Answer

50% HbS is required for the occurrence of sickling.

Answer

HbA prevents sickling.

Answer

50% sickles are present.

Answer

HbA prevents the polymerization of HbS.

Question 10

When milk is taken before a meal, which of the following elements' absorption is decreased?

Accepted Answer

Iron

Answer

Calcium

Answer

Phosphorous

Answer

Magnesium

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?